13:20 UTC+8, 2023-05-26        Neuralink, Elon Musk's brain-machine interface company, announced Thursday it has received approval from the US FDA to conduct its first in-human clinical study.   13:20 UTC+8, 2023-05-26        Neuralink, Elon Musk's brain-machine interface company, announced Thursday it has received approval from the US Food and Drug Administration (FDA) to conduct its first in-human clinical study. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," the company tweeted.

https://www.shine.cn/news/world/2305269051/

#shine